Ginsenoside Rb1 protects brain through Cav-1 for mice with cerebral ischemia-reperfusion injury

doi:10.12092/j.issn.1009-2501.2020.03.004

Abstract

Abstract: AIM: To investigate the protective effect of ginsenoside Rb1 on brain through Cav-1 in mice with cerebral ischemia-reperfusion injury. METHODS: One hundred and twenty C57/B6 mice were randomly divided into sham operation group, model group, model + ginsenoside Rb1 group, ginsenoside Rb1+ Cav-1 siRNA group, ginsenoside Rb1+siNC group, 24 in each group. The model of cerebral ischemia-reperfusion injury in mice was established by middle cerebral artery occlusion (MCAO). The ginsenoside Rb1 group received intraperitoneally injection of ginsenoside Rb1 (40 mg/kg); the sham operation group and model group were intraperitoneally injected with an equal amount of physiological saline immediately after modeling. For the ginsenoside Rb1+ cav-1 siRNA group and the ginsenoside Rb1+siNC group, cav-1 siRNA and siNC were injected into the lateral ventricle 24 h before molding, respectively, and the other operations were the same as the ginsenoside Rb1 group. The neurobehavioral scores of the mice in each group were measured at 24 h after reperfusion, and the water content of brain tissue, cerebral infarction volume, Cav-1 mRNA and Cav-1, Bcl-2 and Bax protein expressions in the cerebral cortex penumbra were measured in each group. RESULTS:Compared with the sham operation group, the neurobehavioral scores, cerebral infarction volume and brain tissue water content in the model group were significantly increased (P<0.05), and the expressions of Cav-1 mRNA and Cav-1 protein, and the Bcl-2 /Bax ratio were significantly decreased (P<0.05). Compared with the model group, the neurobehavioral scores, cerebral infarction volume and brain tissue water content in the ginsenoside Rb1 group were significantly decreased, and the expressions of Cav-1 mRNA and Cav-1 protein, and the Bcl-2 /Bax ratio were significantly increased (P<0.05). Compared with the ginsenoside Rb1 group, the neurobehavioral scores, cerebral infarction volume and brain tissue water content in the ginsenoside Rb1 + cav-1 siRNA group were significantly increased, and the expressions of Cav-1 mRNA and Cav-1 protein, and the Bcl-2 /Bax ratio were significantly decreased (P<0.05). CONCLUSION: Ginsenoside Rb1 can protects brain for mice with cerebral ischemia-reperfusion injury. After Cav-1 siRNA decreased the expression of Cav-1 protein in the brain tissue of mice, it significantly reverses the cerebral protective effect of ginsenoside Rb1, indicating that Cav-1 protein mediated the cerebral protective effect of ginsenoside Rb1 on cerebral ischemia reperfusion injury mice.

Key words: brain ischemia reperfusion injury, ginsenoside Rb1, Cav-1, brain protection

CLC Number:

R965.2

ZHANG Gaojiao, WANG Xinxin, ZHOU Jia, WANG Leilei, DAI Qinxue. Ginsenoside Rb1 protects brain through Cav-1 for mice with cerebral ischemia-reperfusion injury[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(3): 265-270.

References

［1］Guo D, Ma J, Yan L, et al. Down-regulation of lncrna MALAT1 attenuates neuronal cell death through suppressing beclin1-dependent autophagy by regulating mir-30a in cerebral ischemic stroke［J］. Cell Physiol Biochem, 2017, 43(1): 182-194.
［2］Yin KJ, Deng Z, Huang H, et al. miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia［J］. Neurobiol Dis, 2010, 38(1): 17-26.
［3］Zhu J, Jiang Y, Wu L, et al. Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia［J］. Neuroscience, 2012, 202(2): 342-351.
［4］Luo T, Liu G, Ma H, et al. Inhibition of autophagy via activation of PI3K/Akt pathway contributes to the protection of ginsenoside Rb1 against neuronal death caused by ischemic insults［J］. Int J Mol Sci, 2014, 15(9): 15426-15442.
［5］Shota T, Yasushi F. Caveolae-specific caMKII signaling in the regulation of voltage-dependent calcium channel and cardiac hypertrophy［J］. Front Physiol, 2018, 9:1081-1088.
［6］Sohn J, Brick RM, Tuan R. From embryonic development to human diseases: The functional role of caveolae/caveolin［J］.Birth Defects Res C Embryo Today.2016, 108(1): 45-64.
［7］Egawa J, Zemljic-harpf A, Mandyaf CD, et al. Neuron-targeted caveolin-1 promotes ultrastructural and functional hippocampal synaptic plasticity［J］. Cerebral Cortex, 2017, (Pt 2): 1.
［8］Chen HS, Chen X, Li WT, et al. Targeting RNS/caveolin-1/MMP signaling cascades to protect against cerebral ischemia-reperfusion injuries: potential application for drug discovery［J］.Acta Pharmacol Sin,2018,39(5):669-682.
［9］Head BP, Yue H, Cameron F, et al. Neuron-targeted caveolin-1 protein enhances signaling and promotes arborization of primary neurons［J］. J Biol Chem,2011, 286(38): 33310-33321.
［10］Jean-Franois J, Samit M, Manjeet SD, et al. Caveolin-1 deficiency increases cerebral ischemic injury［J］ .Circul Res, 2007, 100(5): 721.
［11］Longga EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats［J］.Stroke, 1989, 20(1): 84.
［12］Dai Q, Geng W, Zhuang X, et al. Electroacupuncture-induced neuroprotection against focal cerebral ischemia in the rat is mediated by adenosine A1 receptors［J］. Neural Regen Res，2017, 12(2): 228-234.
［13］Sandoval KE, Witt K. Blood-brain barrier tight junction permeability and ischemic stroke［J］. Stroke,2008, 32(2): 200-219.
［14］Chen W, Guo Y, Yang W, et al. Protective effect of ginsenoside Rb1 on integrity of blood-brain barrier following cerebral ischemia［J］. Exp Brain Res, 2015, 233(10): 2823-2831.
［15］徐慧，张民远，戴勤学，等.miR-145通过调节SOD活性介导人参皂苷Rb1对脑缺血再灌注损伤大鼠的脑保护作用［J］.中国临床药理学与治疗学, 2018, 23(11): 1215-1220.
［16］Drab M, Verkade P, Elger M, et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice［J］. Science, 2001, 293(5539): 2449-2452.
［17］Zhao YL, Song JN, Zhang M. Role of caveolin-1 in the biology of the blood-brain barrier［J］. Rev Neurosci ,2014, 25(2): 247-254.

[1]	XU Hui，ZHANG Minyuan, DAI Qinxue. MiR-145 regulating SOD activity mediated brain protection of ginsenosides Rb1 in rats with cerebral ischemia-reperfusion injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(11): 1215-1220.
[2]	GUO Jia, LIU Xiao-kang, WU Wen, ZHANG Xiao-wen. Protective effects of preconditioning of Ginsenoside Rb1 on neonatal rat cardiomyocytes against hypoxia-reoxygenation injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(9): 1010-1014.